Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences & IN2UB, University of Barcelona, 08028 Barcelona, Spain.
Int J Mol Sci. 2021 Apr 6;22(7):3784. doi: 10.3390/ijms22073784.
Therapeutic strategies for rare diseases based on exon skipping are aimed at mediating the elimination of mutated exons and restoring the reading frame of the affected protein. We explored the capability of polypurine reverse-Hoogsteen hairpins (PPRHs) to cause exon skipping in NB6 cells carrying a duplication of exon 2 of the gene that causes a frameshift abolishing DHFR activity.
Different editing PPRHs were designed and transfected in NB6 cells followed by incubation in a DHFR-selective medium lacking hypoxanthine and thymidine. Surviving colonies were analyzed by DNA sequencing, RT-PCR, Western blotting and DHFR enzymatic activity.
Transfection of editing PPRHs originated colonies in the DHFR-selective medium. DNA sequencing results proved that the sequence in all these colonies corresponded to the wildtype sequence with just one copy of exon 2. In the edited colonies, the skipping of the additional exon was confirmed at the mRNA level, the DHFR protein was restored, and it showed high levels of DHFR activity.
Editing-PPRHs are able to cause exon skipping at the DNA level and could be applied as a possible therapeutic tool for rare diseases.
基于外显子跳跃的罕见病治疗策略旨在介导突变外显子的消除,并恢复受影响蛋白的阅读框。我们探讨了多聚嘧啶反向 Hoogsteen 发夹(PPRHs)在携带导致移码的基因第 2 外显子重复的 NB6 细胞中引起外显子跳跃的能力,该重复导致 DHFR 活性丧失。
设计了不同的编辑 PPRHs 并转染 NB6 细胞,然后在缺乏次黄嘌呤和胸苷的 DHFR 选择性培养基中孵育。通过 DNA 测序、RT-PCR、Western blot 和 DHFR 酶活性分析存活的集落。
编辑 PPRHs 转染产生了 DHFR 选择性培养基中的集落。DNA 测序结果证明,所有这些集落中的 序列均与仅含有一个 2 号外显子的野生型序列相对应。在编辑的集落中,在 mRNA 水平上证实了额外外显子的跳跃,DHFR 蛋白得以恢复,并表现出高水平的 DHFR 活性。
编辑-PPRHs 能够在 DNA 水平上引起外显子跳跃,可作为治疗罕见病的一种潜在治疗工具。